You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS<br />
Sales From Continuing Operations by Business Sector for years ending<br />
December 31:<br />
Unit: $ mil lions<br />
2008 2007 2006<br />
Pharmaceuticals 26,331 24,025 22,576<br />
Vaccines and Diagnostics 1,759 1,452 956<br />
Sandoz 7,557 7,169 5,959<br />
Consumer Health 5,812 5,426 6,540<br />
TOTAL 41,459 38,072 36,031<br />
Source: Novartis Jan u ary 2009/Novartis An nual Re ports<br />
Pharmaceutical Sales by Therapy Class for years ending December 31:<br />
Unit: $ mil lions<br />
2008* 2007<br />
Cardiovascular and Metabolism 8,183 7,405<br />
Oncology 8,211 6,951<br />
Neuroscience and Ophthalmics 4,605 4,347<br />
Immunology and Infectious Diseases 2,954 2,993<br />
Respiratory 1,084 959<br />
Ophthalmics, Dermatology, Gastrointestinal &Urology — 2,152<br />
Arthritis/Bone — 1,574<br />
Infectious Diseases, Transplantation & Immunology — 1,639<br />
TOTAL 26,331 24,025<br />
Source: Novartis Jan u ary 2009<br />
*Note: For 2008 Novartis re ported sales for five ma jor ther a peu tic ar eas at the be gin ning of 2009.<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 110
Change language